2016
DOI: 10.1016/j.jvir.2015.12.025
|View full text |Cite
|
Sign up to set email alerts
|

Percutaneous Ablation of Hepatic Tumors Using Irreversible Electroporation: A Prospective Safety and Midterm Efficacy Study in 34 Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
25
0
3

Year Published

2016
2016
2021
2021

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 57 publications
(33 citation statements)
references
References 22 publications
5
25
0
3
Order By: Relevance
“…Although IRE is currently used as a ‘last resort treatment’ (patients would otherwise be designated to palliative treatment), efficacy results are moderate [10, 1315]. Local tumor progression (LTP) after IRE ranges between 55 and 93% for colorectal liver metastases (CRLMs) [11].…”
Section: Introductionmentioning
confidence: 99%
“…Although IRE is currently used as a ‘last resort treatment’ (patients would otherwise be designated to palliative treatment), efficacy results are moderate [10, 1315]. Local tumor progression (LTP) after IRE ranges between 55 and 93% for colorectal liver metastases (CRLMs) [11].…”
Section: Introductionmentioning
confidence: 99%
“…included 10 and 43 patients, respectively, but did not specify whether the ablation was complete, nor did they provide clear results on survival. More recently, Niessen et al 28. described a rate of local recurrence of 25.2% in a serie of 34 patients in a 12-month follow-up.…”
Section: Discussionmentioning
confidence: 98%
“…To the best of our knowledge, the present study is the first to evaluate the efficacy of IRE in an animal model with nearly 6 months of follow-up and provides evidence that IRE treatment with a high electric field strength reduces tumor growth and induces a larger percentage of tumor necrosis. In most clinical studies tumor response assessment is based on RECIST criteria, as no histopathological confirmation is routinely obtained1928. A limitation of the animal study would be the lack of imaging monitoring.…”
Section: Discussionmentioning
confidence: 99%
“…They also published results with IRE of 65 hepatic tumors, of which 33 were HCC. In this series, the authors reported an overall complication rate of 27.5% 18. Complications included the following: partial portal vein thrombosis in a cirrhotic patient requiring anti-coagulation (n=1), intraperitoneal bleed requiring intensive care unit admission and transfusion (n=1), abscess formation (n=4), hematomas (n=6), and small, clinically insignificant pneumothoraces (n=2).…”
Section: Ire For Hccmentioning
confidence: 97%